To assess the beneficial and harmful effects of medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
This is a protocol.
Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis
You may also be interested in:
- Rifaximin for people with hepatic encephalopathy
- Aminoglycosides and metronidazole for people with cirrhosis and hepatic encephalopathy
- Naloxone for hepatic encephalopathy
- L-ornithine L-aspartate for people with chronic liver disease and hepatic encephalopathy (poor brain functioning)
- Dopamine agents for hepatic encephalopathy